DaVita reports Q3 adjusted EPS $2.51, consensus $3.17

Reports Q3 revenue $3.42B, consensus $3.43B. “Our Q3 performance was in line with our expectations and keeps us on track to achieve our full-year guidance,” said CEO Javier Rodriguez. “Our consistent focus on providing outstanding care is the key to these results, enabling us to continuously invest in improving the lives of our patients and supporting our dedicated teammates and physician partners.”